Shopping Cart 0
Cart Subtotal
USD 0

bioLytical Laboratories Inc - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

bioLytical Laboratories Inc (bioLytical) is a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that translates into a value proposition. bioLytical provides insti kit which is a rapid antibody test, that detects antibodies of human immunodeficiency virus type one and type two in human whole blood, fingerstick blood, serum and plasma, among others. The company caters tests for diseases such as hepatitis C, Ebola, R and D programs, patients, healthcare professionals, payers, public health organizations, and others. It provides customer care services and markets its products through distributors in Canada and India. bioLytical is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company bioLytical Laboratories Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

bioLytical Laboratories Inc Company Overview 4

bioLytical Laboratories Inc Company Snapshot 4

bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 4

bioLytical Laboratories Inc-Pipeline Analysis Overview 6

bioLytical Laboratories Inc-Key Facts 6

bioLytical Laboratories Inc-Major Products and Services 7

bioLytical Laboratories Inc Pipeline Products by Development Stage 8

bioLytical Laboratories Inc Pipeline Products Overview 10

INSTI Ebola Test 10

INSTI Ebola Test Product Overview 10

INSTI Test-Chikungunya 11

INSTI Test-Chikungunya Product Overview 11

INSTI Test-Dengue 12

INSTI Test-Dengue Product Overview 12

INSTI Test-Hepatitis B 13

INSTI Test-Hepatitis B Product Overview 13

INSTI Test-Hepatitis C 14

INSTI Test-Hepatitis C Product Overview 14

Zika/Flavivirus Test 15

Zika/Flavivirus Test Product Overview 15

bioLytical Laboratories Inc-Key Competitors 16

bioLytical Laboratories Inc-Key Employees 17

bioLytical Laboratories Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

bioLytical Laboratories Inc, Recent Developments 19

Nov 24, 2017: VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day 19

Jul 28, 2017: INSTI HIV Self Test detects HIV two weeks sooner than other brands 19

Jul 28, 2017: Instant HIV home test launched in the Netherlands 20

Jul 27, 2017: INSTI HIV Self Test Demonstrates High User Acceptance in Kenya Study 20

Jul 06, 2017: INSTI HIV Self Test Receives Global Fund Classification for Procurement 20

May 17, 2017: VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test 21

Apr 24, 2017: Instant HIV Home Test Launched in Belgium 22

Feb 21, 2017: BioLytical Receives Innovative Technology Contract from Vizient for Rapid HIV Test 22

Dec 02, 2016: bioLytical Introduces INSTI HIV Self Test to Kenyan Regulated Pharmacy Network 22

Dec 01, 2016: bioLytical Launches INSTI HIV Self Test for African Market in Response to New WHO Guidelines 23

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 27


List Of Figure

List of Figures

bioLytical Laboratories Inc Pipeline Products by Equipment Type 5

bioLytical Laboratories Inc Pipeline Products by Development Stage 8


List Of Table

List of Tables

bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 4

bioLytical Laboratories Inc Pipeline Products by Equipment Type 5

bioLytical Laboratories Inc Pipeline Products by Indication 5

bioLytical Laboratories Inc, Key Facts 6

bioLytical Laboratories Inc, Major Products and Services 7

bioLytical Laboratories Inc Number of Pipeline Products by Development Stage 8

bioLytical Laboratories Inc Pipeline Products Summary by Development Stage 9

INSTI Ebola Test-Product Status 10

INSTI Ebola Test-Product Description 10

INSTI Test-Chikungunya-Product Status 11

INSTI Test-Chikungunya-Product Description 11

INSTI Test-Dengue-Product Status 12

INSTI Test-Dengue-Product Description 12

INSTI Test-Hepatitis B-Product Status 13

INSTI Test-Hepatitis B-Product Description 13

INSTI Test-Hepatitis C-Product Status 14

INSTI Test-Hepatitis C-Product Description 14

Zika/Flavivirus Test-Product Status 15

Zika/Flavivirus Test-Product Description 15

bioLytical Laboratories Inc, Key Employees 17

bioLytical Laboratories Inc, Other Locations 18

Glossary 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

bioLytical Laboratories Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Qualyst Transporter Solutions LLC

Maxim Biomedical Inc

Home Health Care Management Inc

Amplyx Pharmaceuticals Inc

Amico Corp

Alethia Biotherapeutics Inc

Affinity Biologicals Inc

Abt Associates Inc